Literature DB >> 16444373

[Bone mineral density evaluation in inflammatory bowel disease patients].

Fabiana Lígia Lora1, Heda M B Amarante, Júlio C Pisani, Victória V C Borba, Carolina A M Kulak, Eliane R Carmes.   

Abstract

BACKGROUND: Inflammatory bowel disease patients have shown greater reduction of the bone mineral density compared to healthy people. AIM: To evaluate the bone mineral density in a population of patients with inflammatory bowel disease.
METHODS: Ninety patients from 20 to 50 years old, of the Inflammatory Bowel Disease Ambulatory of the Gastroenterology Service of the Clinics Hospital, Curitiba, PR, Brazil, were selected for the evaluation. From those, 76 completed all the stages of the evaluation. The densitometry was made from lumbar column and right femur with a dual-energy x-ray absorptiometry (Hologyc QDR 1000/W) device.
RESULTS: The inflammatory bowel disease patients had a significant reduction of the bone mineral density in all the evaluated parts, femur neck, total femur and lumbar column. The analysed variables, disease activity index, usage of corticoids, the lack of physical activities, the index body mass and previous surgeries did not have influence in the results.
CONCLUSION: Reduced bone mineral density was founded in inflammatory bowel disease patients of the Clinics Hospital, mainly in the Crohn's disease patients, as described in literature. None analyzed variables had significant correlation to the bone mineral density.

Entities:  

Mesh:

Year:  2006        PMID: 16444373     DOI: 10.1590/s0004-28032005000400003

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  3 in total

1.  Chronic gastritis and bone mineral density in women.

Authors:  Adriana M Kakehasi; Carolinne B Rodrigues; Ariane V Carvalho; Alfredo J A Barbosa
Journal:  Dig Dis Sci       Date:  2008-08-07       Impact factor: 3.199

2.  Bone mineral density and inflammatory bowel disease severity.

Authors:  C A Lima; A C Lyra; C M C Mendes; M B Lopes; F G Coqueiro; R Rocha; G O Santana
Journal:  Braz J Med Biol Res       Date:  2017-10-19       Impact factor: 2.590

3.  Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation.

Authors:  Lana Claudinez dos Santos; Aline Villela Costa; Lorrayne Gonçalves Lopes; Alda Jusceline Leonel; Edenil Costa Aguilar; Maria de Lourdes Meirelles Noviello; Maria de Lourdes de Abreu Ferrari; Jacqueline I Alvarez-Leite
Journal:  Med Sci Monit       Date:  2015-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.